Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Neamati

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Expert Opinion on Investigational Drugs|January 12, 2002
A small-molecule antagonist of virion assemblyN Neamati
Expert Opinion on Investigational Drugs|February 15, 2001
Structure-based HIV-1 integrase inhibitor design: a future perspectiveN Neamati
Advances in Virus Research|June 29, 1999
Inhibitors of human immunodeficiency virus integraseY Pommier, N Neamati
Methods in Enzymology|August 10, 2001
In vitro human immunodeficiency virus type 1 integrase assaysC Marchand, N Neamati, Y Pommier
Advances in Pharmacology (San Diego, Calif.)|October 3, 2000
HIV-1 integrase inhibitors: past, present, and futureN Neamati, C Marchand, Y Pommier
Antiviral Research|September 7, 2000
Retroviral integrase inhibitors year 2000: update and perspectivesY Pommier, C Marchand, N Neamati
The Journal of Antibiotics|March 1, 1992
3'-Hydroxyesorubicin halogenated at C-2'W Priebe, N Neamati, R Perez-soler
The Journal of Antibiotics|July 1, 1990
3'-Hydroxyesorubicin. Synthesis and antitumor activityW Priebe, N Neamati, R Perez-Soler
Bioorganic & Medicinal Chemistry Letters|March 4, 2000
Recognition and inhibition of HIV integrase by a novel dinucleotideM Taktakishvili, N Neamati, Y Pommier, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2001
Discovery of a nuclease-resistant, non-natural dinucleotide that inhibits HIV-1 integraseM Taktakishvili, N Neamati, Y Pommier, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Expert Opinion on Investigational Drugs|January 12, 2002
A small-molecule antagonist of virion assemblyN Neamati
Expert Opinion on Investigational Drugs|February 15, 2001
Structure-based HIV-1 integrase inhibitor design: a future perspectiveN Neamati
Advances in Virus Research|June 29, 1999
Inhibitors of human immunodeficiency virus integraseY Pommier, N Neamati
Methods in Enzymology|August 10, 2001
In vitro human immunodeficiency virus type 1 integrase assaysC Marchand, N Neamati, Y Pommier
Advances in Pharmacology (San Diego, Calif.)|October 3, 2000
HIV-1 integrase inhibitors: past, present, and futureN Neamati, C Marchand, Y Pommier
Antiviral Research|September 7, 2000
Retroviral integrase inhibitors year 2000: update and perspectivesY Pommier, C Marchand, N Neamati
The Journal of Antibiotics|March 1, 1992
3'-Hydroxyesorubicin halogenated at C-2'W Priebe, N Neamati, R Perez-soler
The Journal of Antibiotics|July 1, 1990
3'-Hydroxyesorubicin. Synthesis and antitumor activityW Priebe, N Neamati, R Perez-Soler
Bioorganic & Medicinal Chemistry Letters|March 4, 2000
Recognition and inhibition of HIV integrase by a novel dinucleotideM Taktakishvili, N Neamati, Y Pommier, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2001
Discovery of a nuclease-resistant, non-natural dinucleotide that inhibits HIV-1 integraseM Taktakishvili, N Neamati, Y Pommier, et al.
Pageof 5